Author of the publication

CCL-DTI: contributing the contrastive loss in drug-target interaction prediction.

, , , , and . BMC Bioinform., 25 (1): 48 (December 2024)

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Toward a hierarchical virtual screening and toxicity risk analysis for identifying novel CA XII inhibitors., and . Biosyst., (2017)A robust graph-based semi-supervised sparse feature selection method., , , and . Inf. Sci., (2020)Correction to: Moonlighting protein prediction using physico‑chemical and evolutional properties via machine learning methods., , , , and . BMC Bioinform., 22 (1): 366 (2021)NDDSA: A network- and domain-based method for predicting drug-side effect associations., , and . Inf. Process. Manag., 57 (6): 102357 (2020)Moonlighting protein prediction using physico-chemical and evolutional properties via machine learning methods., , , , and . BMC Bioinform., 22 (1): 261 (2021)A Survey on semi-supervised feature selection methods., , , and . Pattern Recognit., (2017)TripletMultiDTI: Multimodal representation learning in drug-target interaction prediction with triplet loss function., , , and . Expert Syst. Appl., (December 2023)In silico drug repositioning of FDA-approved drugs to predict new inhibitors for alpha-synuclein aggregation., , , , and . Comput. Biol. Chem., (2020)Hybrid docking-QSAR studies of DPP-IV inhibition activities of a series of aminomethyl-piperidones., , and . Comput. Biol. Chem., (2016)CCL-DTI: contributing the contrastive loss in drug-target interaction prediction., , , , and . BMC Bioinform., 25 (1): 48 (December 2024)